Scarica l'app Stockscreener
31.06
0.64%
-0.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALKS Giù?
Forum
Previsione
Frazionamento azionario
Alkermes Plc Borsa (ALKS) Ultime notizie
Alkermes Plc Experiences Evaluation Revision Amidst Mixed Market Signals and Performance Trends - Markets Mojo
Alkermes sued over alleged scheme to block generic Vivitrol - Reuters
Is Alkermes plc a good long term investmentMACD Trading Signals & Investor Community Interactions - earlytimes.in
Will Alkermes plc (8AK) stock benefit from Fed rate cuts2025 Market Overview & Comprehensive Market Scan Insights - newser.com
Can Alkermes plc stock deliver strong Q4 earningsPortfolio Growth Summary & Fast Gaining Stock Reports - newser.com
How cyclical is Alkermes plc (8AK) stock compared to rivals2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com
What candlestick patterns are forming on Alkermes plcJuly 2025 Patterns & Fast Gain Stock Trading Tips - newser.com
Will Alkermes plc (8AK) stock hit Wall Street targetsBear Alert & Expert Curated Trade Setups - newser.com
Is Alkermes plc (8AK) stock at risk of policy regulationRisk Management & Weekly Chart Analysis and Trade Guides - newser.com
Is Alkermes plc reversing from oversold territoryEarnings Risk Summary & Risk Controlled Swing Trade Alerts - newser.com
Technical analysis overview for Alkermes plc stockTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Alkermes Plc Hits Day High with Strong 10.58% Intraday Surge - Markets Mojo
Alkermes (ALKS) Added to Wells Fargo's Tactical Ideas List - GuruFocus
What analysts say about Alkermes plc 8AK stockPrice-to-Earnings Ratio Insights & Budget Friendly Capital Growth - earlytimes.in
What drives Alkermes plc stock priceMarket Breadth Indicators & Explosive Profit Trading - earlytimes.in
Alkermes : Corporate Responsability Report - MarketScreener
Alkermes plc (ALKS) Stock Analysis: Exploring a 49.54% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Is Alkermes plc (8AK) stock cheap vs fundamentals2025 Dividend Review & Fast Momentum Stock Entry Tips - newser.com
U.S. Buprenorphine Market Set for Dynamic Growth with Key - openPR.com
How Investors May Respond To Alkermes (ALKS) Phase 2 Alixorexton Narcolepsy Trial Outperformance - Sahm
Alkermes upgraded at RBC Capital Markets ahead of key catalyst - MSN
Is Alkermes' (ALKS) Narcolepsy Drug Breakthrough Shifting Its Investment Narrative? - Yahoo Finance
Alkermes Plc Experiences Evaluation Revision Amid Mixed Market Performance Indicators - Markets Mojo
Alkermes' Stock Dip on Narcolepsy Data Seen as Buying Opportunity, RBC Says - MarketScreener
Alkermes stock upgraded at RBC Capital Markets (ALKS:NASDAQ) - Seeking Alpha
Alkermes (NASDAQ:ALKS) Shares Gap Up After Analyst Upgrade - MarketBeat
Alkermes (NASDAQ:ALKS) Upgraded by Royal Bank Of Canada to "Outperform" Rating - MarketBeat
RBC Capital Upgrades ALKS: Price Target Raised to $44 | ALKS Sto - GuruFocus
RBC Capital Upgrades Alkermes (ALKS) - Nasdaq
RBC Capital Upgrades Alkermes to Outperform From Sector Perform, Adjusts PT to $44 From $42 - MarketScreener
Assenagon Asset Management S.A. Has $2.40 Million Position in Alkermes plc $ALKS - MarketBeat
Nanotechnology Drug Delivery Market Booming Rapidly - openPR.com
Oliver Luxxe Assets LLC Makes New Investment in Alkermes plc $ALKS - MarketBeat
Published on: 2025-09-22 08:18:23 - newser.com
Wedge Capital Management L L P NC Has $3.68 Million Position in Alkermes plc $ALKS - MarketBeat
Atle Fund Management AB Has $6.50 Million Stake in Alkermes plc $ALKS - MarketBeat
Strs Ohio Invests $1.40 Million in Alkermes plc $ALKS - MarketBeat
Voya Investment Management LLC Purchases 27,136 Shares of Alkermes plc $ALKS - MarketBeat
0.83%
9.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):